MEDAPP S.A. ZY -10 Cash Flow Conversion Efficiency

Latest as of December 2025: 0.076x

MEDAPP S.A. ZY -10 cash flow conversion efficiency. Based on the latest financial reports, MEDAPP S.A. ZY -10 (WQ1) has a cash flow conversion efficiency ratio of 0.076x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.04 Million ≈ $2.39 Million USD) by net assets (€26.82 Million ≈ $31.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see WQ1 stock market capitalisation for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of MEDAPP S.A. ZY -10 (2021–2025)

Cash flow conversion efficiency of MEDAPP S.A. ZY -10 from 2021 to 2025. This chart illustrates how MEDAPP S.A. ZY -10's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest MEDAPP S.A. ZY -10 stock price today for real-time trading data and today's change.

MEDAPP S.A. ZY -10 Cash Flow Conversion Ratio Explained

MEDAPP S.A. ZY -10 cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

MEDAPP S.A. ZY -10 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of MEDAPP S.A. ZY -10 ranked by their cash flow conversion efficiency. Review how much free cash does MEDAPP S.A. ZY -10 generate to assess how much free cash flow the company generates relative to operating cash flow.

Company Cash Flow Conversion Efficiency
Starhedge SA
WAR:SHG
-0.004x
SKAKO A/S
CO:SKAKO
0.066x
XWELL Inc.
NASDAQ:XWEL
0.003x
GR BUSSINES SO
F:INW
N/A
Jatcorp Ltd
AU:JAT
0.335x
ARIP Public Company Limited
BK:ARIP
0.160x
Farlim Group (Malaysia) Bhd
KLSE:6041
-0.019x
Battery Age Minerals Ltd
AU:BM8
-0.053x

Annual Cash Flow Conversion Efficiency for MEDAPP S.A. ZY -10 (2021–2025)

The table below shows the annual cash flow conversion efficiency of MEDAPP S.A. ZY -10 from 2021 to 2025. Also see WQ1 total asset value for a full breakdown of the balance sheet.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €26.82 Million
≈ $31.35 Million
€2.44 Million
≈ $2.85 Million
0.091x -37.13%
2024-12-31 €28.84 Million
≈ $33.71 Million
€4.17 Million
≈ $4.87 Million
0.144x +391.16%
2023-12-31 €26.73 Million
≈ $31.25 Million
€-1.33 Million
≈ $-1.55 Million
-0.050x -123.57%
2022-12-31 €27.19 Million
≈ $31.79 Million
€5.72 Million
≈ $6.69 Million
0.210x +1315.77%
2021-12-31 €25.25 Million
≈ $29.52 Million
€-437.00K
≈ $-510.90K
-0.017x --

About MEDAPP S.A. ZY -10

F:WQ1 Germany Health Information Services
Market Cap
$5.97 Million
€5.10 Million EUR
Market Cap Rank
#28193 Global
#2417 in Germany
Share Price
€0.02
Change (1 day)
+0.00%
52-Week Range
€0.01 - €0.07
All Time High
€0.26
About

MedApp S.A. engages in the development of solutions to support imaging diagnostics and digital medicine in Poland, rest of the European Union, and internationally. The company offers CarnaLife Holo, a technology for 3D visualization of imaged medical data which supports the planning and performance of medical procedures. HoloComm, an innovative solution for easy and convenient work on files in 3D… Read more